is present in human plasma at high levels and retains functional activity", "sentences": [], "annotations": [], "relations": []}, {"offset": 48692, "infons": {"fpage": "213", "issue": "3", "lpage": "220", "name_0": "surname:Raffler;given-names:NA", "name_1": "surname:Rivera-Nieves;given-names:J", "name_2": "surname:Ley;given-names:K", "section_type": "REF", "source": "Drug Discov Today Ther Strateg", "type": "ref", "volume": "2", "year": "2005"}, "text": "L-selectin in inflammation, infection and immunity", "sentences": [], "annotations": [], "relations": []}, {"offset": 48743, "infons": {"fpage": "255", "issue": "2", "lpage": "266", "name_0": "surname:Smalley;given-names:DM", "name_1": "surname:Ley;given-names:K", "pub-id_pmid": "15963248", "section_type": "REF", "source": "J Cell Mol Med", "type": "ref", "volume": "9", "year": "2005"}, "text": "L-selectin: mechanisms and physiological significance of ectodomain cleavage", "sentences": [], "annotations": [], "relations": []}, {"offset": 48820, "infons": {"fpage": "2491", "issue": "23", "lpage": "2494", "name_0": "surname:Pignolet;given-names:B", "name_1": "surname:Schwab;given-names:N", "name_2": "surname:Schneider-Hohendorf;given-names:T", "pub-id_pmid": "27815407", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "87", "year": "2016"}, "text": "CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy", "sentences": [], "annotations": [], "relations": []}, {"offset": 48909, "infons": {"fpage": "40", "issue": "1", "lpage": "48", "name_0": "surname:Outteryck;given-names:O", "name_1": "surname:Ongagna;given-names:JC", "name_2": "surname:Brochet;given-names:B", "pub-id_pmid": "23895407", "section_type": "REF", "source": "Eur J Neurol", "type": "ref", "volume": "21", "year": "2014"}, "text": "A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events.